A recipe for headache prevention

In this 'Food as Fuel' Nutritionist Lisa Drayer offers her top foods that fight migraines head on.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news

Related Links:

Abstract Neuropsychiatric adverse events (NPAEs) observed with the integrase strand transfer inhibitor (INSTI) dolutegravir (DTG) are usually mild to moderate. The most prevalent symptoms are insomnia and sleep disorders, but the spectrum also includes dizziness, anxiety, depression, headache, paraesthesia, muscle-skeletal pain, poor concentration, and slow thinking. In recent cohort studies involving>6400 patients in different countries, discontinuation rates due to NPAEs were observed in around 3.5% (range, 1.4-7.2%) of subjects treated with DTG. These rates have been higher than those seen in randomized clin...
Source: AIDS Reviews - Category: Infectious Diseases Authors: Tags: AIDS Rev Source Type: research
SATURDAY, March 23, 2019 -- For people who carry too much weight and suffer from migraines, dropping some pounds might help ease their pain, new research shows. " When people lose weight, the number of days per month with migraine decreases, as does...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Publication date: Available online 23 March 2019Source: Journal of Electroanalytical ChemistryAuthor(s): N. Lavanya, C. SekarAbstractSerotonin is a monoamine neurotransmitter produced from tryptophan and abnormal levels of these molecules have been associated with several disorders, notably depression, migraine, bipolar disorder, anxiety and schizophrenia. In the present work, we have developed a novel electrochemical sensor using SnO2-SnS2 nanocomposite for selective and simultaneous determination of depression biomarkers serotonin (SE) and tryptophan (Trp) in the presence of ascorbic acid (AA). The SnO2-SnS2 composite pr...
Source: Journal of Electroanalytical Chemistry - Category: Chemistry Source Type: research
(The Endocrine Society) For migraine sufferers with obesity, losing weight can decrease headaches and improve quality of life, researchers from Italy and the United States report. The results of their meta-analysis will be presented Saturday, March 23 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
ConclusionRecurrence of medulloblastoma may occur despite more than 15 years of complete remission.Because of this fact it is mandatory to continue the follow-up of these patients.Aggressive management of recurrence is recommended in absence of disease dissemination.
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research
AbstractPurpose of reviewThis review seeks to establish the role of beta-blockers (B-adrenergic receptor antagonists) in the pathophysiology of migraine prophylaxis, compare the efficacy of this group of medications with other common prophylactic agents, and also explore the relative benefits of using individual beta-blockers compared with others.Recent findingsNew evidence supports beta-blockers having several mechanisms of action in migraine prophylaxis. Numerous trials reveal significant clinical differences between various beta-blockers in migraine prophylaxis and that commonly used doses of beta-blockers are not optim...
Source: Current Treatment Options in Neurology - Category: Neurology Source Type: research
Stroke-like episodes (SLEs) are the hallmark of mitochondrial encephalopathy with lactic acidosis and stroke-like episode (MELAS) syndrome but rarely occur also in other specific or nonspecific mitochondrial disorders. Pathophysiologically, SLLs are most likely due to a regional disruption of the blood-brain barrier triggered by the underlying metabolic defect, epileptic activity, drugs, or other factors. SLEs manifest clinically with a plethora of cerebral manifestations, which not only include features typically seen in ischemic stroke, but also headache, epilepsy, ataxia, visual impairment, vomiting, and psychiatric abnormalities.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Tags: Review Article Source Type: research
Condition:   Headache, Migraine Interventions:   Drug: Maxipost;   Drug: Saline Sponsor:   Danish Headache Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Hemodynamics of Cranial Arteries;   Headache;   Cerebral Blood Flow Interventions:   Drug: Levcromakalim;   Drug: Saline Sponsor:   Danish Headache Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Headache, Migraine Interventions:   Drug: Maxipost;   Drug: Saline Sponsor:   Danish Headache Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Headache | Health | Migraine | Nutrition